![](https://vistapglobal.com/wp-content/uploads/2021/12/pexels-brett-sayles-5382986.jpg)
Reportedly, Walmart (WMT), Walgreens Boots Alliance (WBA), and CVS Health Corp (CVS) have limited sales of at-home COVID-19 testing kits as testing demand surges due to the increasing spread of the Omicron variant of the coronavirus. The variant has become a cause of concern, ruining hopes for a more normal holiday season, re-imposing restrictions, and testing the country’s health infrastructure ahead of the holiday season.
Walgreens is reportedly limiting both online and in-store purchases of test kits to four per customer. It also said it was working with suppliers to meet the surging demand. Walmart is reportedly limiting purchases to eight tests for each online order, however, the physical stores are allowed to set their own limits depending on inventory.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.